Biomarker discovery offers a novel therapeutic approach for rheumatoid arthritis
Rheumatoid arthritis (RA) is the most common form of chronic inflammatory arthritis, characterized by synovitis and ...
manilatimes2 天
Alvotech Reports Financial Results for the First Nine Months of 2024
Denosumab targets and binds with high affinity and specificity to the RANK ligand membrane protein, preventing the RANK ...
insertlive1 天
Unlocking the Potential of Peptides in Muscle Cell and Bone Science
Jakarta, - Unlocking the Potential of Peptides in Muscle Cell and Bone Science Peptides, tiny chains of amino acids linked by ...
Alvotech S.A.: Alvotech Reports Financial Results for the First Nine Months of 2024
Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...
BMJ3 天
Not only synovitis but also tenosynovitis needs to be considered: why it is time to update ...
Correspondence to Professor Annette van der Helm-van Mil, Rheumatology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; A.H.M.van_der_Helm{at}lumc.nl Rheumatoid arthritis (RA) is ...